StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $12.37 | $11.61 | -6.14% | 1.8M |
| 05-12 | $12.63 | $13.90 | +10.06% | 3.4M |
| 05-13 | $13.70 | $14.16 | +3.36% | 1.5M |
| 05-14 | $14.37 | $14.60 | +1.60% | 0.9M |
| 05-15 | $14.44 | $14.16 | -1.94% | 0.8M |
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $52.59M | $200.93M | $144.58M | $95.92M |
Operating Income | $-5.09M | $-22.33M | $-19.87M | $-14.48M |
Net Income | $-4.33M | $-18.90M | $-17.26M | $-6.15M |
EPS (Diluted) | $-0.10 | $-0.44 | $-0.40 | $-0.30 |
Total Assets | $242.72M | $238.56M | $234.27M | $230.92M |
Total Liabilities | $63.78M | $61.02M | $62.15M | $60.58M |
Cash & Equivalents | $33.53M | $42.24M | $26.49M | $34.15M |
Free Cash Flow OCF − CapEx | $-3.44M | $-9.09M | $-9.53M | $-8.91M |
Shares Outstanding | 44.20M | 43.65M | 43.27M | 43.01M |